Turning to the set of upregulated miRNAs that could represent direct targets of polycomb, we could show that EZH2 inhibition resulted in upregulation of miRNAs previously reported to be underexpressed in MM. This evidence concerns the gene EZH2 and Miyoshi myopathy.